In this episode of EBRC in Translation, we speak with Jenn Brophy, an assistant professor of Bioengineering at Stanford University. Jenn discusses her journey into plant synthetic biology, including how she transitioned from microbial synthetic biology and her motivation to increase female representation in academia. The conversation explores the current research directions of the Brophy lab, the technical and regulatory challenges in engineering plants versus bacteria, and the potential futu...
All content for EBRC In Translation is the property of EBRC SPA and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of EBRC in Translation, we speak with Jenn Brophy, an assistant professor of Bioengineering at Stanford University. Jenn discusses her journey into plant synthetic biology, including how she transitioned from microbial synthetic biology and her motivation to increase female representation in academia. The conversation explores the current research directions of the Brophy lab, the technical and regulatory challenges in engineering plants versus bacteria, and the potential futu...
In this episode, we interview Dr. Tony Kulesa, a Principal at the VC firm Pillar. We talk to Tony about his work to open source the biotech company creation process, overrated and underrated investment theses, reading and writing to all the different scales of biology and more!To learn more about founder-led biotech, check out some of Tony's writing on the topic here.For more information about EBRC, visit our website at ebrc.org. If you are interested in getting involved with the EBRC St...
EBRC In Translation
In this episode of EBRC in Translation, we speak with Jenn Brophy, an assistant professor of Bioengineering at Stanford University. Jenn discusses her journey into plant synthetic biology, including how she transitioned from microbial synthetic biology and her motivation to increase female representation in academia. The conversation explores the current research directions of the Brophy lab, the technical and regulatory challenges in engineering plants versus bacteria, and the potential futu...
